Dr. Pollard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9800 Shelbyville Rd
Ste 220
Louisville, KY 40223Phone+1 502-429-8585Fax+1 502-429-6157
Education & Training
- University of Louisville School of MedicineFellowship, Allergy and Immunology, 1977 - 1979
- University of Louisville School of MedicineResidency, Pediatrics, 1975 - 1977
- University of Louisville School of MedicineClass of 1975
- University of LouisvilleB.A., Chemistry, 1971
- Kentucky Southern CollegeNo Degree, 1962 - 1963
Certifications & Licensure
- IN State Medical License 1976 - 2025
- KY State Medical License 1976 - 2025
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- One of America's Top Physicians Consumer Research Council, 2005-2006, 2008-2010
- Elected by Peers as One of Louisville's Best Doctors Louisville Magazine, 2001, 2005
- Join now to see all
Clinical Trials
- Clinical Trial of STAHIST in Seasonal Allergic Rhinitis Patients Start of enrollment: 2009 Oct 01
- Study of AHIST in Seasonal Allergic Rhinitis Patients Start of enrollment: 2011 Apr 01
- Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects Start of enrollment: 2010 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 24 citationsComparison of systemic reactions in rush, cluster, and standard-build aeroallergen immunotherapy.Andrew W. Winslow, Joseph C. Turbyville, J. Wesley Sublett, James L. Sublett, Stephen J. Pollard
Annals of Allergy, Asthma & Immunology. 2016-11-01 - Author's response.Joseph C Turbyville, Andrew W Winslow, J Wesley Sublett, James L Sublett, Stephen J Pollard
Annals of Allergy, Asthma & Immunology. 2017-08-01
Journal Articles
- Long-term Safety of nebulized formoterol: Results of a twelve-momth open-label clinical trial in COPDDonohue F, Hanania C, Fogarty S, Campbell C, Rinehart M, Denize-Mize, ( PollardSJ-Study Group), Therapeutic Advances in Respiratory Disease, 1/1/2008
- Evaluation of the Safety and Efficacy of Levalbuterol in 2-5 Year Old Patients with AsthmaSkoner D, Greos L, Kim K, Roach J, Parsey M, Baumgartner R. for the Xopenex Pediatric Study Group (Pollard SJ-Study Group), Pediatric Pulmonology, 6/1/2005
- Efficacy and Tolerability of Montelukast Alone or in Combination with Loratadine in Seasonal Allergic Rrhinitis: a Multicenter, Ramdomized, Double-blind, Placebo-contr...Nayak A, Philip G, Lu S, Malice MP, Reiss, T Montelukast Fall Rhinitis Investigator Group (Pollard SJ-Study Group), Annals of Allergy, Asthma, & Immunology, 6/1/2002
- Join now to see all
Abstracts/Posters
- Safety and Efficacy Experience with Rilonacept (IL-1 Trap) in Adolescents with Cryopyrin-Associated Periodic Syndromes (CAPS)Throne ML, Pollard SJ, Goldstein S, Hoffman HM, Grimes IM, Stein DR, Weinstein SP, Mellis SJ, American College of Rheumatology Annual Scientific Meeting, 1/1/2008
- Effect of Omalizumab on Pulmonary Function and Symptom Scores in Adolescents with Moderate-Servere Persistent IgE-Mediated Asthma.Pollard S J, Maykut B J, Massanari M, Kiawifard F, Zeldin R K, Geba G P, Annals of Allergy, Asthma and Immunology, 1/1/2007
- Effect of Omalizumab on Measures of Control in Adolescents with Moderate-Severe Persistent Asthma.Pollard S J et al, Journal of Allergy and Clinical Immunology, 1/1/2007
- Join now to see all
Lectures
- "Understanding Asthma vs COPD"Brandeburg, KY - 11/1/2009
- "Assessing and Managing Asthma Control"Terra Haute, IN - 8/1/2009
- "Assesing and Managing Asthma Control"Abingdon, VA - 9/1/2008
- Join now to see all
Other
- Recognition and Management of Asthmatic Children.Stephen J. Pollard, MD, Louisville Medicine
4/1/1981 - Comparison of Ipratropium Bromide and Albuterol Sulfate Chlorofluorocarbon metered-dose inhaler and Albuterol Hydrofluoroalkane metered-dose inhaler in a crossover tri...E. R. Bleecker, W. Busse, J. Donohue, S. Garfinkel, T. Lystig, R. C. Manuel, R. Schlenker-Herceg, R. Wise on behalf of the 1012.57 Investigators
Wake Forest University Center of Genomics and Personalized Medicine, Winston Salem
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: